213 related articles for article (PubMed ID: 20148331)
1. The risk of non-sustained ventricular tachycardia after percutaneous alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Klopotowski M; Chojnowska L; Malek LA; Maczynska R; Kukula K; Demkow M; Witkowski A; Dabrowski M; Karcz M; Baranowski R; Kusmierczyk-Droszcz B; Kruk M; Jamiolkowski J; Kusmierczyk M; Szumowski L; Ruzyllo W
Clin Res Cardiol; 2010 May; 99(5):285-92. PubMed ID: 20148331
[TBL] [Abstract][Full Text] [Related]
2. Continuous rhythm monitoring for ventricular arrhythmias after alcohol septal ablation for hypertrophic cardiomyopathy.
Balt JC; Wijffels MC; Boersma LV; Wever EF; ten Berg JM
Heart; 2014 Dec; 100(23):1865-70. PubMed ID: 25073885
[TBL] [Abstract][Full Text] [Related]
3. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy.
Chang SM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
Circulation; 2004 Feb; 109(7):824-7. PubMed ID: 14967729
[TBL] [Abstract][Full Text] [Related]
4. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience.
Nogic J; Koh Y; Bak M; Gooley RP; Meredith IT; McCormick LM
Heart Lung Circ; 2018 Dec; 27(12):1446-1453. PubMed ID: 29129561
[TBL] [Abstract][Full Text] [Related]
5. Mid-ventricular obstruction is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.
Nie C; Zhu C; Xiao M; Yang Q; Meng Y; Wu R; Wang S
Clin Cardiol; 2021 Apr; 44(4):555-562. PubMed ID: 33626191
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
Alam M; Dokainish H; Lakkis NM
Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
[TBL] [Abstract][Full Text] [Related]
7. Cardiac troponin I is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.
Zhou Y; Yu M; Yuan J; Liu S; Hu F; Yang Z; Cui J; Qiao S
Heart Vessels; 2020 Jun; 35(6):876-885. PubMed ID: 31907598
[TBL] [Abstract][Full Text] [Related]
8. Alcohol septal ablation in hypertrophic cardiomyopathy utilizing a longitudinal 17-year study (mean 10.8). Observation follow-ups taken at a single medical centre.
Wojtarowicz A; Kornacewicz-Jach Z
Cardiol J; 2017; 24(2):125-130. PubMed ID: 27734458
[TBL] [Abstract][Full Text] [Related]
9. Rapid Device-Detected Nonsustained Ventricular Tachycardia in the Risk Stratification of Hypertrophic Cardiomyopathy.
Viswanathan K; Suszko AM; DAS M; Jackson N; Gollob M; Cameron D; Spears D; Woo A; Rakowski H; Khurana M; Chauhan VS
Pacing Clin Electrophysiol; 2016 Jul; 39(7):642-51. PubMed ID: 27027856
[TBL] [Abstract][Full Text] [Related]
10. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
11. Procedural complication and long term outcomes after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: data from China.
An SY; Yang YJ; Hang F; Wang ZM; Fan CM
Sci Rep; 2017 Aug; 7(1):9506. PubMed ID: 28842653
[TBL] [Abstract][Full Text] [Related]
12. Gender Disparities in Clinical Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy in the Chinese Han Population: A Cohort Study.
Wang Y; Zhao HW; Wang CF; Meng QK; Cui CS; Zhang XJ; Zhu Y; Fan CY; Luo DF; Chen BJ; Luan B; Hou AJ
Heart Lung Circ; 2020 Dec; 29(12):1856-1864. PubMed ID: 32611501
[TBL] [Abstract][Full Text] [Related]
13. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.
Monserrat L; Elliott PM; Gimeno JR; Sharma S; Penas-Lado M; McKenna WJ
J Am Coll Cardiol; 2003 Sep; 42(5):873-9. PubMed ID: 12957435
[TBL] [Abstract][Full Text] [Related]
14. Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy.
Liu L; Liu S; Shen L; Tu B; Hu Z; Hu F; Zheng L; Ding L; Fan X; Yao Y
Clin Cardiol; 2020 Oct; 43(10):1150-1159. PubMed ID: 32810305
[TBL] [Abstract][Full Text] [Related]
15. Obstructive sleep apnea is associated with nonsustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.
Wang S; Cui H; Song C; Zhu C; Wu R; Meng L; Yu Q; Huang X; Wang S
Heart Rhythm; 2019 May; 16(5):694-701. PubMed ID: 30576881
[TBL] [Abstract][Full Text] [Related]
16. Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
Kazmierczak J; Kornacewicz-Jach Z; Kisly M; Gil R; Wojtarowicz A
Heart; 1998 Sep; 80(3):257-62. PubMed ID: 9875085
[TBL] [Abstract][Full Text] [Related]
17. Non sustained ventricular tachycardia in hypertrophic cardiomyopathy and new ultrasonic derived parameters.
Di Salvo G; Pacileo G; Limongelli G; Baldini L; Rea A; Verrengia M; D'Andrea A; Russo MG; Calabrò R
J Am Soc Echocardiogr; 2010 Jun; 23(6):581-90. PubMed ID: 20362415
[TBL] [Abstract][Full Text] [Related]
18. Complications of low-dose, echo-guided alcohol septal ablation.
Veselka J; Zemánek D; Tomasov P; Homolová S; Adlová R; Tesar D
Catheter Cardiovasc Interv; 2010 Mar; 75(4):546-50. PubMed ID: 20014165
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy.
Francia P; Santini D; Musumeci B; Semprini L; Adduci C; Pagannone E; Proietti G; Volpe M; Autore C
J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1180-7. PubMed ID: 25066044
[TBL] [Abstract][Full Text] [Related]
20. Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy.
Rigopoulos AG; Daci S; Pfeiffer B; Papadopoulou K; Neugebauer A; Seggewiss H
Clin Res Cardiol; 2016 Nov; 105(11):953-961. PubMed ID: 27270758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
